Takeaim Lymphoma- An Open-Label, Dose Escalation And Expansion Trial Of Emavusertib (Ca-4948) In Combination With Ibrutinib In Patients With Relapsed Or Refractory Hematologic Malignancies
Emavusertib;Ibrutinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Takeaim Lymphoma- An Open-Label, Dose Escalation And Expansion Trial Of Emavusertib (Ca-4948) In Combination With Ibrutinib In Patients With Relapsed Or Refractory Hematologic Malignancies ### Output: Emavusertib;Ibrutinib